Feature

CMS finalizes measures to help combat opioid crisis


 


President Trump in March detailed initiatives to address the opioid crisis across three domains: reducing demand through education, awareness, and prevention of overprescribing; reducing illicit drug importation and distribution; and expanding opportunities for proven treatment options.

For prescribers, the president’s plan calls for a nationwide reduction in opioid prescriptions filled by one-third within 3 years. It also looks aims to ensure that 75% of opioid prescriptions paid for by the government are “issued using best practices within 3 years, and 95% within 5 years,” a White House fact sheet notes.

When it comes to federal health care providers, those standards are to be met by half within 2 years and all within 5.

The White House also is calling on states to transition to a nationally interoperable Prescription Drug Monitoring Program (PDMP) network.

Pages

Recommended Reading

Experts review the year in rheumatology ... and what lies ahead
MDedge Rheumatology
FDA alerts doctors to stop administering compounded products
MDedge Rheumatology
Nonopioid analgesics have no major disadvantages vs. opioids for chronic pain
MDedge Rheumatology
Opioid prescriptions got shorter in 2017
MDedge Rheumatology
The case for being open-minded about medical marijuana
MDedge Rheumatology
Intramuscular steroid injection reduced hip OA pain up to 12 weeks
MDedge Rheumatology
MDedge Daily News: Why the barber’s chair can help hypertension
MDedge Rheumatology
Is kratom the answer to the opioid crisis?
MDedge Rheumatology
FDA recalls kratom products for salmonella contamination
MDedge Rheumatology
MDedge Daily News: Does more marijuana mean fewer opioids?
MDedge Rheumatology